Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression

Cancer Research

Volumn 56, Issue 3, 1996, Pages 651-657

  Lokeshwar, Vinata B ^a   Lokeshwar, Bal L ^a,b   Pham, Henri T ^a   Block, Norman L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME SUBSTRATE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ADULT; CULTURE TECHNIQUES; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; HUMANS; HYALURONOGLUCOSAMINIDASE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 0030059196     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zetter, B. R. The cellular basis of site-specific metastasis. N. Engl. J. Med. 322: 605-610, 1990.
2. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L A. Tumor cell interactions with the extracellular matrix during invasion and metastasis Annu. Rev. Cell Biol., 9: 541-573, 1993.
3. McCormick, B. A., and Zetter, B. R Adhesive interactions in angiogenesis and metastasis. Pharmacol. Ther., 53: 239-260, 1992
4. Liotta, L. A., and Stetler-Stevenson, W G Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res., 51: 5045-5095, 1991.
5. Folkman, J. The role of angiogenesis in tumor growth. Sem. Cancer Biol., 3: 65-71, 1992.
6. Kandel, J., Bossy-Wetzel, E., and Radvani, F. Neovascularization is associated with a switch to export b-FGF in the multi-step development of fibrosarcoma. Cell, 66: 1095-1104, 1991.
7. Nguyen, M , Watanabe, H., Budson, A E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl. Cancer Inst., 85: 241-242, 1993
8. West, D. C., Hampson, I. N., Arnold, F , and Kumar, S. Angiogenesis induced by degradation products of hyaluronic acid. Science (Washington DC), 228: 1324-1326, 1985
9. Laurent, T. C , and Fraser, R. E Hyaluronan. FASEB J., 6: 2397-2404, 1992
10. Knudson, W., Biswas, C., Li, X-Q , Nemec, R. E., and Toole, B. P. The role and regulation of tumor-associated hyaluronan. In: J Whelan (ed.), The Biology of Hyaluronan, pp. 150-169. New York: Wiley, Chichester (Ciba Foundation Symposium), 1989.
11. Pauli, B. U., and Knudson, W. Tumor invasion, a consequence of destructive and compositional matrix alterations Hum. Pathol., 19: 628-639, 1988.
12. Knudson, W., Biswas, C., and Toole, B. P. Interactions between human tumor cells and fibroblasts stimulate hyaluronic acid synthesis. Proc. Acad. Sci USA, 81: 6767-6771, 1984.
13. Thomas, L., Etoh, T., Stamenkovic, S., Mihm, M. C., and Byers, H. P. Migration of human melanoma cells on hyaluronate is related to CD44 expression J Invest Dermatol., 100: 115-120, 1993.
14. Hobarth, K., Maier, U., and Marberger, M. Topical chemoprophylaxis of superficial bladder cancer by mitomycin C and adjuvant hyaluronidase. Eur. Urol., 21: 206-210, 1992.
15. West, D. C., and Kumar, S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res., 183: 179-196, 1989
16. Lokeshwar, V. B., and Bourguignon, L Y. W. Hyaluronic acid receptor GP116 is a new CD44 variant in endothelial cells Mol. Cell Biol., 4: 1030, 1993
17. Banarjee, S., and Toole, B. P Hyaluronan binding protein in endothelial cell morphogenesis. J. Cell Biol , 119: 643-652, 1992.
18. Fraser, J. R. E , and Laurent, T C. Turnover and metabolism of hyaluronan. In. J. Whelan (ed ), The Biology of Hyaluronan, pp. 41-59. New York. Wiley, Chicbester (Ciba Foundation Symposium), 1989.
19. Roden, L., Campbell, P., Fraser, J. R. E., Laurent, T. C., Pertoff, H., and Thompson, J. N Enzymatic pathways of hyaluronan catabolism. In: J. Whelan (ed.), The Biology of Hyaluronan, pp. 50-86. New York: Wiley, Chichester (Ciba Foundation Symposium), 1989.
20. Gold, E. W. Purification and properties of hyaluronidase from human liver. Biochem. J., 205: 69-74, 1982.
21. Zhu, L., Hope, T. J., Hall, J , Davies, A., Stern, M., Muller- Eberhard, U., Stern, R., and Parslow, T. G. Molecular cloning of a mammalian hyaluronidase revels identity with hemopexin, a serum heme-binding protein. J. Biol. Chem., 269: 32092-32097, 1994.
22. Toole, B. P. Glycosaminoglycans in morphogenesis. In: E. D Hay (ed.), Cell Biology of the Extracellular Matrix, pp. 1384-1386. New York: Plenum Publishing Corp., 1991.
23. Stern, M , Longkar, M. T., Adzick, N. S., Hamson, H. R., and Stern, R. Hyaluronidase levels in urine from Wilms' tumor patients. J. Natl. Cancer Inst., 83: 1569-1574, 1991.
24. Gleason, D. F. Classification of prostate carcinomas. Cancer Chemother. Rep., 50 (Part 1): 125-130, 1966
25. Lokeshwar, B. L., Selzer, M. G., Block, N. L., and Smith, Z. G. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res., 53: 4493-4498, 1993.
26. Gutenhoner, N. W., Pogrel, M. A., and Stern, R. A. Substrate gel assay for hyaluronidase activity. Matrix, 12: 388-396, 1992.
27. Stern, M., and Stern, R. An ELISA-like assay for hyaluronidase hyaluronidase inhibitor. Matrix, 12: 397-403, 1992.
28. Lim, D. J , Liu, X-I., Stukowski, D. M., Braun, E. J., Lee, C , and Kozlowski, J. M. Growth of an androgen sensitive prostate cancer cell line. LNCaP, in nude mice. Prostate, 22: 109-118, 1993.
29. Guo, Y., Pili, R., and Passanti, A. Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix. Prostate, 24: 1-10, 1994
30. Afify, A M., Stern, M., Gutenhoner, M., and Stern, R. Purification and characterization of human serum hyaluronidase Arch. Biochem. Biophys., 305: 434-441, 1993.
31. De Salegui, M., Polanska, H., and Pigman, W. A comparison of serum and testicular hyaluronidase Arch. Biochem. Biophys., 121: 548-554, 1967.
32. Dahl, M., Solheim, O. P. Erikstein, B., and Muller, E. A longitudinal study on the hyaluronan level in the serum of patients with malignant mesothelioma under treatment, hyaluronan as an indicator of progressive disease. Cancer (Phila.), 64: 68-73, 1989.
33. Kumar, S., West, D C , Ponting, J. M. and Gattamaneni, H R. Sera of children with renal tumors contain low molecular-mass hyaluronic acid. Int. J Cancer, 44: 445-448, 1989
34. 2+-dependent endocytic hyaluronan receptor in rat liver sinusoidal cells using a photoaffinity crosslinking reagent. J Biol. Chem , 267: 20451-20456, 1992.
35. Wike-Hooley, J L., Haveman, J., and Reinhold, H. S. The relevance of tumor pH to the treatment of malignant disease. Radiother. Oncol., 2: 343-366, 1984.
36. Schumer, J., Klocker, J., Tidstrand, J., Rab, B , and Allmayer, H Cisplatin, vindesine and hyaluronidase combined with simultaneous radiotherapy of advanced head and neck tumors Onkologie, 47: 310-312, 1990.
37. Beckenlehner, K., Bannke, S., Spruss, T., Bernhardt, G., Schonenberg, H., and Schiess, W. Hyaluronidase enhances the activity of Adriamycin in breast cancer models in vitro and in vivo J Cancer Res & Clin. Oncol., 118 591-596, 1992.